#ESMO21
Thierry Conroy reports on key results from ESMO Congress 2021 on LBA57 - Unicancer GI PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter randomized phase 3 trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas.
Produced by the European Society for Medical Oncology
http://oncologypro.esmo.org
Watch video #ESMO21 online without registration, duration hours minute second in high quality. This video was added by user European Society for Medical Oncology (ESMO) 19 September 2021, don't forget to share it with your friends and acquaintances, it has been viewed on our site 2,281 once and liked it 17 people.